发明名称 |
Peptide and peptide analog protease inhibitors |
摘要 |
Methods of use of compounds and compounds for the treatment of disorders characterized by the cerebral deposition of amyloid are provided. Among the compounds are those of formulae I and II: <IMAGE> I <IMAGE> II in which R1 is preferably 2-methyl propene, 2-butene, cyclohexyl or cyclohexylmethyl; R2, R4, and R8 are each independently methyl or ethyl; R3 is preferably iso-butyl or phenyl; R5 is preferably iso-butyl; R6 is H or methyl; R7-(Q)n is preferably benzyloxycarbonyl or acetyl; Q is preferably -C(O)-; RB is preferbly iso-butyl; RA=-(T)m-(D)m-R1, is which T is preferably oxygen or carbon, and D is preferably a mono-unsaturated C3-4 alkenyl being more preferred; and X is preferably an alpha -ketoester or alpha -ketoamide or aldehyde. |
申请公布号 |
AU4697296(A) |
申请公布日期 |
1996.07.24 |
申请号 |
AU19960046972 |
申请日期 |
1996.01.05 |
申请人 |
THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. |
发明人 |
IAN ALEXANDER MCDONALD;ELISABETH ALBRECHT;BENITO MUNOZ;BLAKE ALAN ROWE;ROBERT STEVEN SIEGEL;STEVEN LEE WAGNER |
分类号 |
A61K38/00;A61K31/00;A61P25/00;A61P25/16;A61P25/28;C07C237/22;C07K5/02;C07K5/06;C07K5/065;C07K5/078;C07K5/08;C07K5/083 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|